ALK and neoplasm: No significant correlation was found between the expression of EP300 and gender, age, Programmed Cell Death 1 Ligand 1 (PDL1) expression, Anaplastic Lymphoma Receptor Tyrosine Kinase (ALK) expression, tumor size, tumor differentiation, and N stage.